Results 21 to 30 of about 786,681 (194)
Positive HBs antigen in the absence of hepatitis B virus infection [PDF]
Annales de Biologie Clinique, John Libbey Eurotext, 2019, 77 (5),
pp.543-548, 2019 French recommendations for the screening of hepatitis B virus (HBV) infection were updated in 2019 with the association of three markers: HBs Ag, anti-HBs Ab and anti-HBc Ab. These three markers allow identification of infected patients, vaccinated patients and patients who have been in contact with HBV. A positive HBs Ag is usually associated with HBV
arxiv +1 more source
Barriers to accessing hepatitis B medication: a qualitative study from the USA and Canada
BMJ OpenObjectives To collect and document the numerous barriers that people living with hepatitis B (PLHB) encounter when trying to access their hepatitis B virus (HBV) medications.Design Researchers collected qualitative data through 24 online interviews.
Sophie Jacob +5 more
doaj +1 more source
Quantitative Kinetic Models from Intravital Microcopy: A Case Study Using Hepatic Transport [PDF]
The Journal of Physical Chemistry B, 2019, 2019 The liver performs critical physiological functions, including metabolizing and removing substances, such as toxins and drugs, from the bloodstream. Hepatotoxicity itself is intimately linked to abnormal hepatic transport and hepatotoxicity remains the primary reason drugs in development fail and approved drugs are withdrawn from the market.
arxiv +1 more source
Harm Reduction JournalBackground People who use drugs (PWUD) are at increased risk for blood-borne viruses, including hepatitis B (HBV) and delta (HDV). Despite the public health threats both viruses present, awareness remains low among at-risk communities and providers who ...
Beatrice Zovich +9 more
doaj +1 more source
VirusesThe prevalence of hepatitis B and delta viruses (HBV/HDV) among people who use drugs (PWUD) remains largely unknown. In the context of one Philadelphia-based harm reduction organization (HRO), this study aimed to assess HBV/HDV prevalence and facilitate ...
Beatrice Zovich +10 more
doaj +1 more source
An age-structured model of hepatitis B viral infection highlights the potential of different therapeutic strategies [PDF]
arXiv, 2021 Hepatitis B virus is a global health threat, and its elimination by 2030 has been prioritised by the World Health Organisation. Here we present an age-structured model for the immune response to an HBV infection, which takes into account contributions from both cell-mediated and humoral immunity.
arxiv
Text Classification of Cancer Clinical Trial Eligibility Criteria [PDF]
arXiv, 2023 Automatic identification of clinical trials for which a patient is eligible is complicated by the fact that trial eligibility is stated in natural language. A potential solution to this problem is to employ text classification methods for common types of eligibility criteria.
arxiv
Frontiers in Public HealthIntroductionAsian and Pacific Islander (API), African, and Caribbean immigrant groups in the U.S. are disproportionately impacted by chronic hepatitis B and hepatocellular carcinoma (primary liver cancer).
Beatrice Zovich +7 more
doaj +1 more source
Survey of lived experiences and challenges in hepatitis B management and treatment
BMC Public HealthAlmost 300 million people are living with chronic hepatitis B infection worldwide and most remain undiagnosed and at risk for liver cancer. In 2015 the World Health Organization (WHO) developed guidelines for the prevention, care, and treatment of ...
Catherine Freeland +7 more
doaj +1 more source
The burden of chronic hepatitis B virus infection in Australia, 2011
Australian and New Zealand Journal of Public Health, 2013 Objective: The number of Australians living with chronic hepatitis B (CHB) is thought to be increasing, as are adverse outcomes including cirrhosis and liver cancer, however, robust, up‐to‐date estimates of this burden are limited. Contemporary estimates
Jennifer H. MacLachlan +3 more
doaj +1 more source